Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab
Inbal Shafran, Farideh Alasti, Josef S Smolen, Daniel Aletaha
Topics & Concepts
MedicineTocilizumabRheumatoid arthritisInternal medicineC-reactive proteinMethotrexateRituximabGastroenterologyAcute-phase proteinArthritisClinical trialImmunologyInflammationLymphomaRheumatoid Arthritis Research and TherapiesInflammatory Biomarkers in Disease PrognosisHematological disorders and diagnostics